The distribution of mut samples according to the mutation detection criteria, >1000×cov and >5% AF, >500×cov and >5%, and >1000×cov and <5% AF was, respectively: in 49 KRAS2–4/NRAS2–4/BRAF15 mut (77.8%), 40 (63.5%), 8 (12.7%), 1 (1.6%); in 42 (66.7%) KRAS2–4 mut, 32 (50.8%), 9 (14.3%), 1 (1.6%); in 40 (63.5%) KRAS2 mut, 30 (47.6%), 9 (14.3%), 1 (1.6%); in 11 (16.4%) NRAS2–4 mut, 7 (10.4%), 1 (1.5%), 3 (4.5%); in 5 (7.5%) BRAF15 mut, 1 (1.5%) at >500×cov and >5% AF, 4 (6%) at >1000×cov and <5% AF. Here, KRAS is linked to atrial fibrillation.